Welcome to BIOMED
BIOMED™ is an American biotechnology company advancing healthcare through innovation, improving access, and delivering smarter, more efficient medical solutions. We offer personalized and precision medicine that adapts to each individual’s health profile, using advanced technologies like 3D bioprinting, Big Data, DNA, and AI-driven modeling to deliver precise dosages, timing, and drug combinations. Our platform is built to enhance patient outcomes, reduce inefficiencies, and help shape the future of medicine, one person at a time.
Artificial Intelligence/Machine Learning
The complexity and rise of data in healthcare means that artificial intelligence (AI) & Machine Learning will increasingly be applied to our health. One of BIOMED's key application categories involves diagnosis and treatment recommendations, patient engagement and adherence, and future applications in administrative activities.
Drug Delivery & Discovery
Our research spans activities in contemporary chemical biology and drug discovery and blends the principles and experimental techniques of chemistry and biology with computational science.
3D Bioprinting (Additive Manufacturing)
This federal initiative aims to use today’s 3D printing technologies to improve supply chain resilience for American manufacturers. By accelerating the adoption of additive manufacturing (AM) across small and medium-sized companies, each of these AM-powered manufacturers will, in turn, contribute to building resilient supply chains for the U.S.-based domestic manufacturing ecosystem while also using 3D printing to improve their industrial competitiveness.
Partner with Us
Send your request and let one of our experts care about it.
Meet Our Specialists
Let us introduce our entire team of experts who make the success of our business.
Matt Strathman
Chief Legal Officer / IM (Industrial Mentor)
Bobby D. Ntoya, MBA
CEO / PI/EL (Principal Investigator/Entrepreneur Lead)
Gregory Taylor II, MD, MBA
Chief Medical Officer / PI/TL (Principal Investigator/Technical Lead)I’ve been an advisor to the BIOMED team for several years, and I’m excited about the research of 3D tissue bioprinting operational model, specifically in the regulation of pulmonary epithelial cell differentiation.
Our Research
Here is a short list of our most promising technologies. Innovation and commercialization of our technologies is the most important aspect of our commitment to our patients.
3D Tissue Bioprinting
About 90 percent of potential new drugs fail in clinical trials because they are...
Cannabidiol Research
Cannabis and Cannabidiol Research Expansion Act 2022, The bipartisan legislation rolled back federal restrictions...
Precision and Personalized Medicine
In his 2015 State of the Union address, President Obama announced that he launched...
Artificial Intelligence / Machine Learning
The complexity and rise of data in healthcare means that artificial intelligence (AI) &...
Latest News
Read here all our recent press releases, news, blogs, tips, reports, and everything related to Biomed and the biotechnology field
The Future of mRNA Is Personal: How BIOMED Sees mRNA as a Catalyst for Precision and Personalized Medicine.
mRNA rose to global prominence during the COVID-19 pandemic. However, we believe mRNA’s most significant contribution is just beginning. At its core, messenger RNA (mRNA) technology is about sending...
Continue Reading
medibles, a BIOMED company, Partners with the NIH All of Us Research Program to advance the Future of Personalized and Precision Medicine
At medibles, we believe the future of medicine is precise and personalized. Today, we’re excited to share a significant step forward in that vision. Medibles, the personalized health and...
Continue Reading
New Study, Pharmaceutical Companies Losing Billions After States Legalize Cannabis
The legalization of cannabis has had a significant effect on pharmaceutical companies. A new study research project titled “U.S. Cannabis Laws Projected to Cost Generic, and Brand Pharmaceutical Firms Billions” used CRSP...
Continue Reading
BIOMED, Chosen As A Top Ten Finalists For The MedTech Color 2023 Pitch Competition
Today, Los Angeles, February 10, 2023 /PRNewswire/ — BIOMED, the leading next-generation healthcare platform, was chosen as one of the top ten finalists for the MedTech Color 2023 Pitch...
Continue Reading
Paxlovid reduces serious risks from Omicron variants
As we continue to navigate the evolving landscape of COVID-19, new data shows promising strides in protecting vulnerable populations, especially older adults, from serious outcomes. A recent study led...
Continue Reading
Research Studies Show CBD Can Help With Endometriosis?
According to the World Health Organization, endometriosis is an often painful disorder that affects approximately 10% of women worldwide. Endometriosis grows endometrial-like tissue (uterine lining cells) in locations outside the uterus, including ovaries,...
Continue Reading
Federal Reserve Bank states Cannabis Industry Has Boosted Economic Activity in Several States
Cannabis legalization has been an enormous success with a significant economic impact. The new report from this Federal Reserve Bank district shows how cannabis-related businesses create jobs and generate...
Continue ReadingHow CBD Can Help with Mental Health
Today, mental health is a mounting concern in our society. More and more people are struggling with conditions like anxiety and depression, and traditional treatments often don’t help or...
Continue ReadingNew Research: Neuroimaging research shows the potential of CBD’s protective properties
Nowadays almost every single person cares about aesthetic, their need to be accepted make them search for new and revolutionary treatments, we have seen an explosion of alternatives, it...
Continue Reading